|
NPX887 Clinical Trials
1 actively recruiting trial across 1 location
Baltimore, Maryland1 trial
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.